Key facts
- This page summarizes Aesther Healthcare Sponsor, LLC's Form 4 filing for Aesther Healthcare Acquisition Corp. (OCEA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2021, 15:35.
Aesther Healthcare Sponsor, LLC - 03 Nov 2021 Form 4 Insider Report for Aesther Healthcare Acquisition Corp. (OCEA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- OCEA
- Reported as of
- 03 Nov 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2021, 15:35:16 UTC
- Prior SEC filing
- 21 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Suren Ajjarapu, as Manager of Aesther Healthcare Sponsor, LLC
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Aesther Healthcare Sponsor, LLC filed Form 4 for Aesther Healthcare Acquisition Corp. (OCEA) on 16 Dec 2021.
Change
- Previous filing in this sequence was filed on 21 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCEAW
transaction
Derivative
Class B common stock
Other
- Transaction value
- Shares
- -250,000
- Change %
- -8.7%
- Price
- Shares after
- 2,625,000
- Date
- 03 Nov 2021
- Ownership
- Direct
- Underlying class
- Class A common stock
- Underlying amount
- 250,000
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This Form 4 reflects the automatic surrender to the issuer of 250,000 shares of the issuer's Class B common stock, par value $0.0001 per share ("Class B Shares"), for no consideration by Aesther Healthcare Sponsor, LLC (the "Sponsor") pursuant to contractual arrangements with the issuer, triggered by the expiration of the option of the underwriters of the issuer's initial public offering to purchase additional units.
Footnote F2
As described in the issuer's registration statement on Form S-1 (File No. 333-258012) under the heading "Description of Securities-Founder Shares", the Class B Shares will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date.
Footnote F3
Suren Ajjarapu is the managing member of the Sponsor and Chief Executive Officer of the Issuer. As such, Mr. Ajjarapu may be deemed to have beneficial ownership of such shares. Mr. Ajjarapu disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.